Angewandte Chemie
10.1002/ange.202004991
COMMUNICATION
Scheme 1. Reaction of Juv Mod6-Pik TE with Tyl hexaketide 3 results in pyran 13, which is identical in mass to
macrolactone 8. This outcome was only achieved via extension of Tyl hexaketide through Juv Mod6-Pik TE and
hydrolytic offloading to the linear seco acid 11, which can rapidly interconvert to the hemiketal containing product 12.
Finally, the hemiketal is spontaneously dehydrated to produce the observed pyran 13. Stereochemistry displayed is
that of the native product 11 and subsequent hemiketalization (12). *represent likely points of inverted stereochemistry
seen in the isolated product.
extent of this limitation and overcome it, we generated a series of
type I PKS modules fused with TE domains from three related
biosynthetic pathways and assessed each for catalytic activity
Acknowledgements
with select polyketide substrates to emulate the final catalytic
steps in engineered pathways. Although the TE interactions are
not the only factor involved in polyketide assembly and offloading
We gratefully acknowledge NIH grant R35 GM118101, and the
Hans W. Vahlteich Professorship (D.H.S.). This research was
partially supported by Rackham Merit Predoctoral Fellowships
(
e.g. Juv Mod6 hybrids fail to process 2, Table 2), we achieved
robust catalysis of non-native substrates through PKS modules
when the TE domain was matched with the substrate from its
native PKS. In addition to explaining the attenuated yields of
polyketides obtained from engineered PKSs described in
previous studies,[7] the current work generates further
experimental support for the critical role of the TE domain in the
processing of unnatural intermediates. These results are in
accord with allied efforts performed in fungal iterative PKSs, which
(
D.A.H. and A.A.K.), T32-CA009676 (A.A.K. training fellowship),
and an American Foundation for Pharmaceutical Education
Predoctoral Fellowship (D.A.H.). We thank Dr. Zachary Litman
for critical reading of this manuscript.
Keywords: Polyketides • Biosynthesis • Biocatalysis • Natural
products • PKS Engineering
identified the TE domain as a key gatekeeper in the production of
fungal polyketides.[9]
[1]
K. J. Weissman, Nat. Prod. Rep. 2016, 33, 203-230.
a) R. McDaniel, A. Thamchaipenet, C. Gustafsson, H. Fu, M.
[
2]
Betlach, M. Betlach, G. Ashley, Proc. Natl. Acad. Sci. U. S. A.
Furthermore, our results indicate that identity of the TE
domain may also alter the sequence of catalytic events that
occurs in engineered PKS modules. This possibility is highlighted
by the product divergence when DEBS Mod6 TE hybrids process
the unnatural substrate 2, giving either 6 (3-keto) or 7 (3-hydroxy)
macrolactones predominantly (Figure 1). Recent work from
Kalkreuter et al. also noted the gatekeeper role of the KR by
observing that assembly of unnatural polyketide intermediates
resulted in a propensity to skip the PKS module reductive step,
setting keto functionality at the respective C-atom.[10] Future
structural and protein engineering studies will focus on delineating
the role of the TE domain in the processing of unnatural
substrates. By exploring how non-native TE domains can
contribute to diminished product formation observed with
combinatorial biosynthesis and directed pathway engineering
strategies, we will be able to more effectively design bacterial type
I PKS pathways for enhanced production of polyketide natural
product analogs, a long-standing goal in secondary metabolite
biosynthesis and synthetic biology.[1, 3, 11]
1999, 96, 1846-1851; b) Q. Xue, G. Ashley, C. R. Hutchinson, D.
V. Santi, Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 11740-11745; c)
J. R. Jacobsen, A. T. Keatinge-Clay, D. E. Cane, C. Khosla,
Bioorg. Med. Chem. 1998, 6, 1171-1177; d) T. Leaf, L. Cadapan,
C. Carreras, R. Regentin, S. Ou, E. Woo, G. Ashley, P. Licari,
Biotechnol. Prog. 2000, 16, 553-556; e) K. Kinoshita, P. G Williard,
C. Khosla, D. E. Cane, J. Am. Chem. Soc. 2001, 123, 2495-2502;
f) C. J. Harvey, J. D. Puglisi, V. S. Pande, D. E. Cane, C. Khosla,
J. Am. Chem. Soc. 2012, 134, 12259-12265.
[
[
3]
4]
J. D. Kittendorf, D. H. Sherman, Bioorg. Med. Chem. 2009, 17,
2137-2146.
a) D. A. Hansen, C. M. Rath, E. B. Eisman, A. R. Narayan, J. D.
Kittendorf, J. D. Mortison, Y. J. Yoon, D. H. Sherman, J. Am.
Chem. Soc. 2013, 135, 11232-11238; b) D. A. Hansen, A. A. Koch,
D. H. Sherman, J. Am. Chem. Soc. 2015, 137, 3735-3738; c) A. N.
Lowell, M. D. DeMars, S. T. Slocum, F. Yu, K. Anand, J. A.
Chemler, N. Korakavi, J. K. Priessnitz, S. R. Park, A. A. Koch, P. J.
Schultz, D. H. Sherman, J. Am. Chem. Soc. 2017, 139, 7913-
7920.
[5]
a) J. D. Mortison, J. D. Kittendorf, D. H. Sherman, J. Am. Chem.
Soc. 2009, 131, 15784-15793; b) K. Watanabe, C. C. C. Wang, C.
N. Boddy, D. E. Cane, C. Khosla, J. Biol. Chem. 2003, 278, 42020-
42026; c) Y. Yin, H. Lu, C. Khosla, D. E. Cane, J. Am. Chem. Soc.
2
003, 125, 5671-5676.
E. Kalkreuter, G. J. Williams, Curr. Opin. Microbiol. 2018, 45, 140-
48.
a) D. A. Hansen, A. A. Koch, D. H. Sherman, J. Am. Chem. Soc.
017, 139, 13450-13455; b) A. A. Koch, D. A. Hansen, V. V.
[
[
6]
7]
1
2
Shende, L. R. Furan, K. N. Houk, G. Jiménez-Osés, D. H.
Sherman, J. Am. Chem. Soc. 2017, 139, 13456-13465.
This article is protected by copyright. All rights reserved.